“You’ve got to start with the customer experience and work backwards to the technology. You can’t start with the technology and try to figure out where can I sell it.” -Steve Jobs UNIMOON is tokenizing on Polygon Matic. We are building a layer 1 solution building on substrate and auction for a Polkadot parachain. We will be the first interoperable decentralized social media network partnering with Storj for our decentralized cloud data storage needs. Enabling users to have full ownership and control of their personal information where it is displayed and how it is displayed utilizing blockchain technology for storage of key information. UNIMOON is bridging the gap between web2.0 to web3.0 solving the greatest issue of adoption for blockchain technology in the simplest way possible starting with the user experience.

DexBerry is a next-generation decentralized ecosystem Mega-Application backed by a revolutionary smart contract technology. The Mission of DexBerry is to leverage ever-evolving blockchain technologies to provide users with an application that supports easy access to cross-chain liquidity and tools for fast, easy, and secure acquisition of digital assets without moving from one project feature to another. With DexBerry, users can Analyze, Advertise, Acquire, Create, Compete, Earn, Game, Launch, Swap & more without moving 1 INCH.

The first Cross-Chain Interoperable DeFi Ecosystem, built natively on Avalanche The ActaFi Ecosystem brings a complete DeFi suite that incentivises user-base growth and motivates the user activity, offering both DeFi products and features in a single ecosystem. Every interaction within the ActaFi Ecosystem is executed on-chain, by smart contracts.

Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

Lohn is a widely spread contractual form in various industrial fields of international cooperation relations, especially in the industry of clothing, footwear, leather, furniture, software and hardware, pharmaceutical, metal working, metallurgical, machine tools, automotive, automation, machine building industry, electronics and appliance industry, food and beverage industry, petrochemical industry. The lohn (processing economy) has been and will be a solution to produce goods at reasonable and high-quality prices through the efficient use of labor and cheap raw materials in emerging economies. It is also a business model that creates economic and social progress across the world bringing together markets with productive resources and capabilities. The trading platform developed by the lohncontrol project will create global opportunities for small and medium-sized businesses that are responsible for generating 60% of GDP. It will give them a visibility that they do not have at this time and will encourage the development of direct business between them. This means low manufacturing costs and greater adaptation to market demands. Those who will win at the end of this interaction will be consumers who will get good products at realistic prices.